Clinical Profiles and Proton Pump Inhibitor Discontinuation Outcomes in Laryngopharyngeal Reflux Disease.

Objective: To investigate the clinical presentation and weaning of patients with chronic proton pump inhibitor (PPI) therapy and laryngopharyngeal reflux disease (LPRD).

Study Design: Prospective controlled study.

Methods: Patients with LPRD symptoms despite ongoing PPI therapy were prospectively recruited from two centers.